Clinical Trial Update: Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates using circulating tumor DNA to guide post-operative therapy decisions in patients with HPV-associated oropharyngeal cancer and is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer

Snippet

Sponsor: Zachary Zumsteg | Conditions: Oropharyngeal Cancer, Carcinoma | Phase 2 | Status: RECRUITING